Insider: MCCOURT Thomas A Chief Executive Officer - IRONWOOD PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,489,002 | 0 | 1,489,002 |
| Value | $5,807,107.80 | $0.00 | $5,807,107.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/24/2026 | DDS | 103,526 | Direct | COM | $3.66 | $378,905.16 | 1,489,002 |
| 02/23/2026 | DDS | 94,757 | Direct | COM | $3.81 | $361,024.17 | 1,592,528 |
| 05/16/2025 | DDS | 13,353 | Direct | COM | $0.58 | $7,744.74 | 1,147,281 |
| 02/10/2025 | DDS | 139,064 | Direct | COM | $1.76 | $244,752.64 | 1,160,634 |
| 05/20/2024 | DDS | 67,618 | Direct | COM | $6.45 | $436,136.10 | 1,150,330 |
| 02/12/2024 | DDS | 177,164 | Direct | COM | $15.24 | $2,699,979.36 | 832,774 |
| 05/30/2023 | DDS | 26,632 | Direct | COM | $10.70 | $284,962.40 | 758,284 |
| 05/22/2023 | DDS | 36,000 | Direct | COM | $10.12 | $364,320.00 | 784,916 |
| 05/08/2023 | DDS | 21,148 | Direct | COM | $10.62 | $224,591.76 | 820,916 |
| 03/27/2023 | DDS | 46,129 | Direct | COM | $10.67 | $492,196.43 | 842,064 |
| 03/03/2023 | DDS | 33,756 | Direct | COM | $11.22 | $378,742.32 | 647,598 |
| 02/28/2023 | DDS | 26,639 | Direct | COM | $11.31 | $301,287.09 | 685,942 |
| 02/28/2023 | DDS | 4,588 | Direct | COM | $11.31 | $51,890.28 | 681,354 |
| 02/27/2023 | DDS | 25,595 | Direct | COM | $11.41 | $292,038.95 | 716,990 |
| 02/27/2023 | DDS | 4,409 | Direct | COM | $11.41 | $50,306.69 | 712,581 |
| 01/05/2023 | DDS | 110,962 | Direct | COM | $12.07 | $1,339,311.34 | 712,440 |
| 10/03/2022 | DDS | 18,899 | Direct | COM | $10.41 | $196,738.59 | 712,440 |
| 09/01/2022 | DDS | 26,446 | Direct | COM | $10.65 | $281,649.90 | 731,339 |
| 08/01/2022 | DDS | 23,229 | Direct | COM | $11.35 | $263,649.15 | 757,785 |
| 06/30/2022 | DDS | 19,959 | Direct | COM | $11.58 | $231,125.22 | 778,922 |
| 05/23/2022 | DDS | 2,587 | Direct | COM | $11.50 | $29,750.50 | 832,602 |
| 05/23/2022 | DDS | 21,873 | Direct | COM | $11.50 | $251,539.50 | 810,729 |
| 05/23/2022 | DDS | 11,848 | Direct | COM | $11.50 | $136,252.00 | 798,881 |
| 02/28/2022 | DDS | 1,942 | Direct | COM | $10.77 | $20,915.34 | 632,802 |
| 02/28/2022 | DDS | 10,026 | Direct | COM | $10.77 | $107,980.02 | 622,776 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research